Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)

Core Viewpoint - Spectral AI has regained compliance with Nasdaq Listing Rule 5550(b)(2), maintaining a market value of over $35 million for the last 10 consecutive business days [1][2]. Company Overview - Spectral AI, based in Dallas, focuses on predictive AI for medical diagnostics, particularly in wound care, with applications for burn and diabetic foot ulcer patients [3]. - The company's DeepView System utilizes multi-spectral imaging and algorithms to assess wound healing potential, aiming to improve treatment decisions and patient outcomes while reducing healthcare costs [3]. Compliance Details - The company has notified Nasdaq of its compliance status and is awaiting confirmation from the exchange regarding its market value [2].